文献速递间质性肺疾病

纤维化间质性肺疾病症状负担的整体管理

Holistic management of symptom burden in fibrosing interstitial lung diseases (F-ILDs).
PubMed 文献 · Thorax · 2026-06-09

本综述总结纤维化间质性肺疾病(F-ILD)症状负担的管理策略。疾病修饰治疗虽延缓生理功能下降,但未一致改善患者报告症状或健康相关生活质量。管理应包括呼吸困难、慢性咳嗽、疲劳及心理困扰的非药物与药物干预,并整合氧疗、肺康复和早期姑息治疗。

要点

  • 呼吸困难管理包括非药物干预、个性化自我管理及晚期选择性使用低剂量阿片类药物。
  • 慢性咳嗽可采用行为与言语治疗、治疗胃食管反流等合并症及止咳治疗。
  • 肺康复应早期整合并维持,可改善运动能力、症状负担和生活质量。

核心结论

  • F-ILD患者症状负担重,需在抗纤维化治疗同时提供全面支持治疗。
  • 多学科护理模式有助于在整个疾病轨迹中提供个体化整体护理。

研究设计与样本

  • 综述总结了F-ILD症状管理策略的当前证据。

主要发现

  • 呼吸困难、慢性咳嗽、疲劳、焦虑和抑郁在F-ILD中高度流行并显著损害日常功能。
  • 氧疗改善氧合,但对呼吸困难和症状的效果不一。
  • 肺康复可改善运动能力、症状负担和健康相关生活质量,并带来心理益处。

临床怎么用

  • 呼吸困难管理可包括非药物干预、个性化自我管理及晚期选择性使用低剂量阿片类药物。
  • 慢性咳嗽可采取行为与言语治疗、治疗胃食管反流等合并症及止咳治疗。
  • 疲劳和心理困扰需常规筛查、评估可改变因素并针对性干预。
  • 肺康复应早期整合并尽可能维持。
  • 鉴于F-ILD轨迹不可预测,应早期整合姑息治疗,讨论预后、预立护理计划和终末期偏好。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Disease modifying therapies for progressive fibrotic interstitial lung diseases (F-ILDs) slow physiological decline but have not consistently shown to improve patient-reported symptoms or health-related quality of life. Patients with F-ILD experience a substantial symptom burden that necessitates comprehensive supportive care alongside antifibrotic treatment. This review summarises the current evidence for management strategies for F-ILD to be considered in conjunction with disease-modifying therapies. SYMPTOM MANAGEMENT: Dyspnoea, chronic cough, fatigue, anxiety and depression are highly prevalent in F-ILD and significantly impair daily functioning. Dyspnoea management includes non-pharmacological interventions, personalised self-management strategies and selective use of low dose opioids in advanced disease though overall benefit may be modest. Chronic cough may be addressed through behavioural and speech therapy, treatment of contributing comorbidities such as gastro-oesophageal reflux disease and antitussive therapies, including neuromodulators and low dose opioids for refractory symptoms. Fatigue and psychological distress require routine screening, evaluation of modifiable factors and targeted interventions. OXYGEN THERAPY: Oxygen therapy remains a standard of care for patients with resting or exertional hypoxaemia. While it improves oxygenation, its effect on dyspnoea and symptoms is variable, underscoring the importance of individualised assessment and patient-centred decision making. PULMONARY REHABILITATION: Pulmonary rehabilitation provides evidence-based improvements in exercise capacity, symptom burden and health-related quality of life. It also offers important psychological benefits and should be integrated early and maintained as feasible throughout the disease course. PALLIATIVE CARE: Given the unpredictable trajectory of F-ILD, early integration of palliative care is essential. Discussions regarding prognosis, advance care planning and end of life preferences, supported by a multidisciplinary care model, enable holistic, goal concordant care across the progressive disease trajectory. A multidisciplinary care model is beneficial for providing individualised, holistic care throughout the patient's progressive disease trajectory.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Krishna R, Lindell K. Holistic management of symptom burden in fibrosing interstitial lung diseases (F-ILDs). Thorax. 2026. PMID: 42264936. doi:10.1136/thorax-2024-222056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。